Created as a remote-first company, CellmatiQ’s team is unimpacted by Covid-19 and continues its medical AI development. We are proud of the next major release of the fully automated cephalometric analysis. Improved AI accuracy, polished UI/UX, RESTful API for integration into 3rd party software, and more. Available for trial and use at https://ortho.dentaliq.ai or https://analyse-now.de (in Germany through DAMPSOFT GmbH). The associated peer-reviewed study is available from Springer (https://link.springer.com/article/10.1007/s00056-019-00203-8). The next AI products are already in development…